More mangos, less problems? Research continues to reveal that may be the case. According to a new review of scientific literature, mangos and the individual compounds they contain, may mitigate the chance of metabolic and inflammation-associated disease. The comprehensive research was recently published in Food & Function.
The review identified 11 articles measuring the impact of mango consumption on obesity, including seven human trials of individuals who were obese or diagnosed with type 2 diabetes. These results suggest that mangos could help balance glucose response in those with diabetes mellitus.
The inclusive data also shows that mangos contain various phytochemicals including phenolic acids, mangiferin, carotenoids, and gallotannins. These components are connected to a range of health-promoting activities including anti-inflammation, antioxidant, anti-diabetic, anti-obesity, and anti-cancer.
This is the first review to focus on the impact of the flesh and pulp of the mango, as previous papers centered on the bark, leaves, peels, and seeds of the fruit. The research, Mangos and their bioactive components: adding variety to the fruit plate for health, was led by Dr. Britt Burton-Freeman, Director of the Center for Nutrition Research at the Illinois Institute of Technology.
Looking forward, this study opens up possible pathways for further research into human health benefits of mangoes. The study suggests a possible connection between eating mangoes for systematic and gut health, and vascular and brain health.